Haemoglobin Glycosilate as a Glycemic Control at Type 2 Diabetes 
Mellitus Patients 
Rusdiana
1 *
, Maya Savira
2 
, Sry Suryani Widjaja
1
 
1 
Departement  of  Biochemistry, Medical Faculty of Universitas Sumatera Utara, Jl. dr. Mansur, Universitas Sumatera 
Utara, Medan, 20155
2 
Departement of Physiology, Medical Faculty of Universitas Sumatera Utara, Jl. dr. Mansur, Universitas Sumatera Utara,
Medan, 20155 
Keywords:   Diabetes Mellitus Type 2, Fasting Blood Sugar, Haemoglobin Glycosylate. 
Abstract:  Chronic disease that characterized by blood glucose levels that exceed normal values is Diabetes Mellitus. 
The patient of type 2 diabetes mellitus must controlled their bood sugar level and the most accurate way to 
determine  blood  sugar  levels  over  the  past  to  three  months  by  Hba1c  measurement.This  study  was  to 
determine the levels of blood sugar and Hba1c in patients with type 2 diabetes mellitus in  Johor Primary 
Health Care (PHC) in Medan of Sumatera Utara, Indonesia. This study used cross-sectional design conducted 
in Johor PHC, Medan of Sumatera Utara, 40 patients with type 2 diabetes mellitus. All the samples of fasting 
blood sugar and HbA1c were recorded for each patient who attend to the PHC . We collected the primary data 
through interviews, physical examination and laboratory test. More than half of the samples of  this study  
have  bad Hba1c levels (>8% ) cause of many patients   of  type 2 diabetes mellitus lack of knowledge about 
the correct management of diabetes mellitus.
1  INTRODUCTION 
One of the public health problem and a major clinical 
is Diabetes mellitus, taht requires continuing medical 
care and ingoing patient management education and 
support to prevent acute complication and to reduce 
the  risk long-term  complication.  All over  the world 
the precalence of type 2 diabetes mellitus id rapidly 
increasing. In 2011, the global prevalence of diabetes 
was 366 million and caused 4.6 million deaths (IDF). 
This figure is expected to rise to 522 million by 2030 
and will be 7th leading cause of death in 2030 (IDF 
2012,  WHO  2011).  Indonesia  is  the  world’s  fourth 
most  populated  country,  has  the  seventh  largest 
number  of  diabetic  patients(7.6  million),  despite 
relatively  low  prevalence  (4,8%  including  both 
diabetes type 1 and 2 in individuals aged 20-79 years) 
in 2012  (IDF, 2012).  Because of  its high  morbidity 
and mortality diabetes mellitus is an important health 
problem (King H et al, 1998), Indonesia is the country 
with  the  largest  numbers  of  people  with  diabetes 
(Shaw JE,2010, Wild et al, 2004). In urban Indonesia 
of  the  prevalence  of  diabetes  mellitus  is  5.7% 
(Mihardja  L  et  al,  2009),  and  a  younger  age  of  the 
incidence of diabetes mellitus is starting to rise (Chan 
JC et al, 2009). 
According American Diabetis Association(ADA) 
glycemic control as one of the important strategies for 
the  management  of  DM  and  glycosylated 
haemoglobin (Hbalc) is the best measure of glycemic 
level  over  the  previous  3  months.  Hbalc  is  udes  to 
monitor  diabetic  treatment  each  3  months  once 
because  of  the  erythrocyte  haemoglobinglycation 
since erythrocytes have about 120 days life span, and 
reflects overall blood glucose levels over a period 2-
3 months and further, in the achievement of the best 
possible glycemic control it has been recognized that 
hbalc  as  an  essential  adjunct  to  regular  self-blood 
glucose  measurement  assisting  (Saudek  CD  et  al, 
2009).  The  health  of  individuals  and  communities 
depended  many  factors  which  was  influenced.  The 
low education  level is one  of these factors  which is 
linked  poor  health,  more  stress  and  lower  self-
confidence. This aim of study to determine the levels 
of Hbalc in patients with type 2 diabetes mellitus in 
Johor PHC in Medan of North Sumatera, Indonesia. 
2  MATERIAL AND METHODS 
Patients  were  recruited  from  Medan  Johor  Primary 
Health  Care  (PHC),North  Sumatera,  Indonesia.This